<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Dark Blogs Case Study 01 - A European Pharmaceutical Group</title>
	<atom:link href="http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group/feed" rel="self" type="application/rss+xml" />
	<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group</link>
	<description>Picking out patterns in the chaos</description>
	<pubDate>Wed, 16 May 2012 20:50:14 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
		<item>
		<title>By: Moderne-Unternehmenskommunikation.de</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1816</link>
		<dc:creator>Moderne-Unternehmenskommunikation.de</dc:creator>
		<pubDate>Fri, 07 Sep 2007 13:28:07 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1816</guid>
		<description>&lt;strong&gt;Blogs als pragmatisches Kommunikationsinstrument: Fallbeispiel&lt;/strong&gt;

Autor: Jörg Hoewner
Blogs eignen sich für den Intraneteinsatz als ein schnell aufzusetzendes, kosteneffizientes Mittel, um Mitarbeiter über Marktentwicklungen, Projekte oder Innovationen auf dem laufenden zu halten und sie darüber über die blog-immanen...
</description>
		<content:encoded><![CDATA[<p><strong>Blogs als pragmatisches Kommunikationsinstrument: Fallbeispiel</strong></p>
<p>Autor: Jörg Hoewner<br />
Blogs eignen sich für den Intraneteinsatz als ein schnell aufzusetzendes, kosteneffizientes Mittel, um Mitarbeiter über Marktentwicklungen, Projekte oder Innovationen auf dem laufenden zu halten und sie darüber über die blog-immanen&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Traction®  Software Inc &#124; Public</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1815</link>
		<dc:creator>Traction®  Software Inc &#124; Public</dc:creator>
		<pubDate>Wed, 19 Apr 2006 22:54:05 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1815</guid>
		<description>&lt;strong&gt;European Pharmaceutical Group deploys Traction for Intelligence and KM&lt;/strong&gt;

A pharmaceutical group based in Europe with world wide facilities and over 1 billion Euros in 2005 revenue deployed Traction TeamPage enterprise blog software as a Competitive Intelligence platform. Traction enables a collective intelligence process s...
</description>
		<content:encoded><![CDATA[<p><strong>European Pharmaceutical Group deploys Traction for Intelligence and KM</strong></p>
<p>A pharmaceutical group based in Europe with world wide facilities and over 1 billion Euros in 2005 revenue deployed Traction TeamPage enterprise blog software as a Competitive Intelligence platform. Traction enables a collective intelligence process s&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: HealthCareVox</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1814</link>
		<dc:creator>HealthCareVox</dc:creator>
		<pubDate>Wed, 01 Mar 2006 21:46:42 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1814</guid>
		<description>&lt;strong&gt;Questions For Steve Rubel&lt;/strong&gt;

As many of you know, I will be interviewing Steve Rubel of Micro Persuasion tomorrow afternoon about healthcare blogging.&#160; In an earlier post, I promised to publish the questions I'll be asking Steve for the blogging community to comment on/add...
</description>
		<content:encoded><![CDATA[<p><strong>Questions For Steve Rubel</strong></p>
<p>As many of you know, I will be interviewing Steve Rubel of Micro Persuasion tomorrow afternoon about healthcare blogging.&nbsp; In an earlier post, I promised to publish the questions I&#8217;ll be asking Steve for the blogging community to comment on/add&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mark Williams</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1813</link>
		<dc:creator>Mark Williams</dc:creator>
		<pubDate>Wed, 15 Jun 2005 17:49:27 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1813</guid>
		<description>Interesting that the company chose to restrict permission to publish original content to an editorial team. While this does ensure help to ensure that the style and content of what is published is consistent and of a high standard, it does not encourage active mass participation. I suppose it depends somewhat on the objectives of the company but it in this case the social nature of the application has been limited.
</description>
		<content:encoded><![CDATA[<p>Interesting that the company chose to restrict permission to publish original content to an editorial team. While this does ensure help to ensure that the style and content of what is published is consistent and of a high standard, it does not encourage active mass participation. I suppose it depends somewhat on the objectives of the company but it in this case the social nature of the application has been limited.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: andrew</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1812</link>
		<dc:creator>andrew</dc:creator>
		<pubDate>Tue, 14 Jun 2005 09:22:38 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1812</guid>
		<description>Very interesting and well structured,
</description>
		<content:encoded><![CDATA[<p>Very interesting and well structured,</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Allan</title>
		<link>http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1811</link>
		<dc:creator>Allan</dc:creator>
		<pubDate>Tue, 14 Jun 2005 08:36:52 +0000</pubDate>
		<guid isPermaLink="false">http://strange.corante.com/2005/06/13/dark-blogs-case-study-01-a-european-pharmaceutical-group#comment-1811</guid>
		<description>Congratulations Suw on getting this one done and published.  It is a great piece and I know how hard it is to get permission to publish anything of this nature.

As they asy in the story: Can I have some more, please? :-)
</description>
		<content:encoded><![CDATA[<p>Congratulations Suw on getting this one done and published.  It is a great piece and I know how hard it is to get permission to publish anything of this nature.</p>
<p>As they asy in the story: Can I have some more, please? <img src='http://strange.corante.com/wp-includes/images/smilies/icon_smile.gif' alt=':-)' class='wp-smiley' /></p>
]]></content:encoded>
	</item>
</channel>
</rss>

